Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin + Metformin in Drug-Naive T2D with Poor Control
NCT00468039Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Mar 2007; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00468039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468039.